Pinnacle Biologics owns the marketing and distribution rights to MedImmune’s Ethyol, 50mg/ml, powder for solution for infusion in Western Europe, Turkey and Israel.
Guillermo Herrera, chairman of the board at Pinnacle Biologics, said: “This is a highpoint for Pinnacle, as it signifies an additional milestone for our company.”